A detailed history of Advisor Net Financial, Inc transactions in Organon & Co. stock. As of the latest transaction made, Advisor Net Financial, Inc holds 1,643 shares of OGN stock, worth $24,152. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,643
Previous 1,712 4.03%
Holding current value
$24,152
Previous $32,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 13, 2025

SELL
$14.44 - $18.83 $996 - $1,299
-69 Reduced 4.03%
1,643 $24,000
Q3 2024

Oct 15, 2024

BUY
$18.65 - $23.03 $2,275 - $2,809
122 Added 7.67%
1,712 $32,000
Q2 2024

Jul 16, 2024

BUY
$17.45 - $21.96 $1,483 - $1,866
85 Added 5.65%
1,590 $32,000
Q1 2024

Apr 12, 2024

BUY
$13.78 - $18.8 $17,252 - $23,537
1,252 Added 494.86%
1,505 $28,000
Q4 2023

Jan 19, 2024

SELL
$10.95 - $17.32 $963 - $1,524
-88 Reduced 25.81%
253 $3,000
Q3 2023

Oct 12, 2023

SELL
$16.59 - $23.77 $11,065 - $15,854
-667 Reduced 66.17%
341 $5,000
Q2 2023

Jul 14, 2023

BUY
$19.27 - $24.63 $2,138 - $2,733
111 Added 12.37%
1,008 $20,000
Q1 2023

Apr 28, 2023

BUY
$21.42 - $32.08 $664 - $994
31 Added 3.58%
897 $21,000
Q4 2022

Jan 13, 2023

SELL
$23.31 - $28.61 $4,918 - $6,036
-211 Reduced 19.59%
866 $0
Q3 2022

Oct 04, 2022

BUY
$23.4 - $34.25 $7,604 - $11,131
325 Added 43.22%
1,077 $25,000
Q2 2022

Jul 07, 2022

SELL
$31.66 - $38.9 $1,488 - $1,828
-47 Reduced 5.88%
752 $25,000
Q1 2022

Apr 14, 2022

SELL
$30.45 - $39.36 $548 - $708
-18 Reduced 2.2%
799 $28,000
Q4 2021

Jan 19, 2022

SELL
$28.67 - $37.13 $22,706 - $29,406
-792 Reduced 49.22%
817 $25,000
Q3 2021

Oct 15, 2021

BUY
$28.63 - $35.64 $46,065 - $57,344
1,609 New
1,609 $53,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.74B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.